These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 33465670)

  • 1. Oxaliplatin derived monofunctional triazole-containing platinum(II) complex counteracts oxaliplatin-induced drug resistance in colorectal cancer.
    Li Y; Sun Z; Cui Y; Zhang H; Zhang S; Wang X; Liu S; Gao Q
    Bioorg Chem; 2021 Feb; 107():104636. PubMed ID: 33465670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monofunctional platinum(II) complexes with potent tumor cell growth inhibitory activity: the effect of a hydrogen-bond donor/acceptor N-heterocyclic ligand.
    Margiotta N; Savino S; Gandin V; Marzano C; Natile G
    ChemMedChem; 2014 Jun; 9(6):1161-8. PubMed ID: 24799414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. trans,cis,cis-bis(benzoato)dichlorido(cyclohexane-1R,2R-diamine)platinum(IV): a prodrug candidate for the treatment of oxaliplatin-refractory colorectal cancer.
    Gandin V; Marzano C; Pelosi G; Ravera M; Gabano E; Osella D
    ChemMedChem; 2014 Jun; 9(6):1299-305. PubMed ID: 24715720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of chirality on the anticancer activity of Pt(II) and Pt(IV) complexes containing 1
    Papadia P; Barbanente A; Ditaranto N; Hoeschele JD; Natile G; Marzano C; Gandin V; Margiotta N
    Dalton Trans; 2021 Nov; 50(43):15655-15668. PubMed ID: 34673864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. cis-Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects.
    Lovejoy KS; Todd RC; Zhang S; McCormick MS; D'Aquino JA; Reardon JT; Sancar A; Giacomini KM; Lippard SJ
    Proc Natl Acad Sci U S A; 2008 Jul; 105(26):8902-7. PubMed ID: 18579768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ASR352, A potent anticancer agent: Synthesis, preliminary SAR, and biological activities against colorectal cancer bulk, 5-fluorouracil/oxaliplatin resistant and stem cells.
    Narayan S; Ramisetti S; Jaiswal AS; Law BK; Singh-Pillay A; Singh P; Amin S; Sharma AK
    Eur J Med Chem; 2019 Jan; 161():456-467. PubMed ID: 30384048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose-conjugated platinum(IV) complexes as tumor-targeting agents: design, synthesis and biological evaluation.
    Wang H; Yang X; Zhao C; Wang PG; Wang X
    Bioorg Med Chem; 2019 Apr; 27(8):1639-1645. PubMed ID: 30852077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platinum(II) complexes of imidazophenanthroline-based polypyridine ligands as potential anticancer agents: synthesis, characterization, in vitro cytotoxicity studies and a comparative ab initio, and DFT studies with cisplatin, carboplatin, and oxaliplatin.
    Alexander C; Nithyakumar A; Paul MWB; Arockia Samy N
    J Biol Inorg Chem; 2018 Jul; 23(5):833-848. PubMed ID: 29934700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxaliplatin-incorporated micelles eliminate both cancer stem-like and bulk cell populations in colorectal cancer.
    Wang K; Liu L; Zhang T; Zhu YL; Qiu F; Wu XG; Wang XL; Hu FQ; Huang J
    Int J Nanomedicine; 2011; 6():3207-18. PubMed ID: 22238509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression MGP inhibits tumor proliferation and reverses oxaliplatin resistance in colorectal cancer.
    Huang C; Wang M; Wang J; Wu D; Gao Y; Huang K; Yao X
    Biochem Pharmacol; 2021 Jul; 189():114390. PubMed ID: 33359068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-hydroxybutyrate resensitizes colorectal cancer cells to oxaliplatin by suppressing H3K79 methylation in vitro and in vivo.
    Deng M; Yan P; Gong H; Li G; Wang J
    Mol Med; 2024 Jun; 30(1):95. PubMed ID: 38910244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Luminescent Pt
    Lázaro A; Balcells C; Quirante J; Badia J; Baldomà L; Ward JS; Rissanen K; Font-Bardia M; Rodríguez L; Crespo M; Cascante M
    Chemistry; 2020 Feb; 26(9):1947-1952. PubMed ID: 31909511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methyl 6-Amino-6-deoxy-d-pyranoside-Conjugated Platinum(II) Complexes for Glucose Transporter (GLUT)-Mediated Tumor Targeting: Synthesis, Cytotoxicity, and Cellular Uptake Mechanism.
    Li T; Gao X; Yang L; Shi Y; Gao Q
    ChemMedChem; 2016 May; 11(10):1069-77. PubMed ID: 27135196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platinum(IV) complexes conjugated with phenstatin analogue as inhibitors of microtubule polymerization and reverser of multidrug resistance.
    Huang X; Huang R; Gou S; Wang Z; Liao Z; Wang H
    Bioorg Med Chem; 2017 Sep; 25(17):4686-4700. PubMed ID: 28728896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homo- and hetero-dinuclear Pt(II)/Pd(II) complexes: studies of hydrolysis, nucleophilic substitution reactions, DNA/BSA interactions, DFT calculations, molecular docking and cytotoxic activity.
    Ćoćić D; Jovanović-Stević S; Jelić R; Matić S; Popović S; Djurdjević P; Baskić D; Petrović B
    Dalton Trans; 2020 Oct; 49(41):14411-14431. PubMed ID: 33043330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA CACS15 contributes to oxaliplatin resistance in colorectal cancer by positively regulating ABCC1 through sponging miR-145.
    Gao R; Fang C; Xu J; Tan H; Li P; Ma L
    Arch Biochem Biophys; 2019 Mar; 663():183-191. PubMed ID: 30639170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression analysis of genes involved in oxaliplatin response and development of oxaliplatin-resistant HT29 colon cancer cells.
    Plasencia C; Martínez-Balibrea E; Martinez-Cardús A; Quinn DI; Abad A; Neamati N
    Int J Oncol; 2006 Jul; 29(1):225-35. PubMed ID: 16773204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic and biological characteristics of different sugar conjugated 2-methyl malonatoplatinum(II) complexes as new tumor targeting agents.
    Gao X; Liu S; Shi Y; Huang Z; Mi Y; Mi Q; Yang J; Gao Q
    Eur J Med Chem; 2017 Jan; 125():372-384. PubMed ID: 27688191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and structure-activity relationships of tetrazolato-bridged dinuclear platinum(II) complexes: A small modification at tetrazole C5 markedly influences the in vivo antitumor efficacy.
    Komeda S; Yoneyama H; Uemura M; Tsuchiya T; Hoshiyama M; Sakazaki T; Hiramoto K; Harusawa S
    J Inorg Biochem; 2019 Mar; 192():82-86. PubMed ID: 30612029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxaliplatin resistance in colorectal cancer cells is mediated via activation of ABCG2 to alleviate ER stress induced apoptosis.
    Hsu HH; Chen MC; Baskaran R; Lin YM; Day CH; Lin YJ; Tu CC; Vijaya Padma V; Kuo WW; Huang CY
    J Cell Physiol; 2018 Jul; 233(7):5458-5467. PubMed ID: 29247488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.